$29.51
1.01% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US14843C1053
Symbol
CSTL

Castle Biosciences Inc Stock News

Neutral
Business Wire
6 days ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle's executive management will present a company overview at the Piper Sandler 36th Annual Healthcare Conference on Dec. 4, 2024, at 10:50 am ET.
Neutral
Business Wire
7 days ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle has been named a Houston Top Workplace by the Houston Chronicle for the 4th straight year and has earned 3 national Culture Excellence awards.
Neutral
Business Wire
18 days ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #ASDP24--Castle will share new data highlighting the clinical performance of its DecisionDx-Melanoma and MyPath Melanoma tests at the ASDP 61st Annual Meeting.
Neutral
Business Wire
19 days ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CastleBiosciences--Castle's TissueCypher Barrett's Esophagus test surpassed 25,000 test reports delivered since the Company acquired the test at the end of 2021.
Neutral
Business Wire
20 days ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--New data demonstrates Castle's DecisionDx-Melanoma test can accurately identify patients with a low risk of metastasis who can safely forgo SLNB.
Neutral
Seeking Alpha
22 days ago
Castle Biosciences, Inc. (NASDAQ:CSTL ) Q3 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Company Participants Camilla Zuckero - VP, IR and Corporate Affairs Derek Maetzold - Founder, President and CEO Frank Stokes - CFO Conference Call Participants Kyle Mikson - Canaccord Genuity Corey Rosenbaum - Scotiabank Thomas Flaten - Lake Street Mason Carrico - Stevens Puneet Souda - Leerink ...
Neutral
Business Wire
22 days ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #CSTL--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the third quarter and nine months ended September 30, 2024. “We are thrilled with our third quarter performance, which reflects the continued success of our growth initiatives and the ...
Neutral
Business Wire
28 days ago
FRIENDSWOOD, Texas--(BUSINESS WIRE)---- $CSTL #ACG2024--New data at ACG 2024 demonstrates ability of TissueCypher to significantly reduce healthcare costs associated with management of Barrett's esophagus.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today